Inventor · disambiguated record
Paul Bunn
Also filed as: BUNN JR PAUL A · BUNN PAUL · BUNN PAUL A · BUNN PAUL A JR
10 granted patents·12 pending applications·442 citations·filing 1993–2016
90Inventor score
Top patents by PatentIndex Score
22 records- 0197US5411730AMagnetic microparticlesRES CORP TECHNOLOGIES INC·Filed 1993·Granted May 2, 1995·239 cites·13 claims
- 0291US6048550AHydrophilic microparticles and methods to prepare sameFiled 1997·Granted Apr 11, 2000·123 cites·16 claims
- 0383US8575170B2Flurbiprofen analogs and methods of use in treating cancerGERA LAJOS·Filed 2011·Granted Nov 5, 2013·6 cites·17 claims
- 0483US7427496B2Anti-cancer compoundsUNIV COLORADO·Filed 2005·Granted Sep 23, 2008·2 cites·4 claims
- 0578US7071168B2Anti-cancer compounds and methods related theretoUNIV COLORADO·Filed 2001·Granted Jul 4, 2006·7 cites·4 claims
- 0677US6388054B1Anti-cancer compoundsFiled 1999·Granted May 14, 2002·28 cites·11 claims
- 0772US7858349B2Anti-cancer compoundsUNIV COLORADO·Filed 2008·Granted Dec 28, 2010·0 cites·5 claims
- 0871US8017321B2Gefitinib sensitivity-related gene expression and products and methods related theretoUNIV COLORADO REGENTS·Filed 2005·Granted Sep 13, 2011·3 cites·4 claims
- 0968US5980935ACationic lipids and methods of use thereforFiled 1996·Granted Nov 9, 1999·34 cites·16 claims
- 1059US2012141479A1Histone Deacetylase Inhibitors Sensitize Cancer Cells To Epidermal Growth Factor InhibitorsWITTA SAMIR E·Filed 2008·Application pending·0 cites
- 1157US2007281034A1Magnetic microparticles comprising organic substancesKIRPOTIN DMITRI B·Filed 2007·Application pending·0 cites
- 1255US2007197568A1Methods of using SAHA and Erlotinib for treating cancerBUNN PAUL·Filed 2006·Application pending·0 cites
- 1355US2008182865A1Histone deacetylase inhibitors sensitize cancer cells to epidermal growth factor inhibitorsWITTA SAMIR E·Filed 2007·Application pending·0 cites
- 1454US2010196366A1Gefitnib Sensitivity-Related Gene Expression and Products and Methods Related TheretoBUNN PAUL A·Filed 2008·Application pending·0 cites
- 1550US2008090233A1Methods for Prediction of Clinical Outcome to Epidermal Growth Factor Receptor Inhibitors by Cancer PatientsUNIV COLORADO·Filed 2005·Application pending·0 cites
- 1649US2017029901A1Methods for prediction of clinical outcome to epidermal growth factor receptor inhibitors by cancer patientsUNIV COLORADO REGENTS·Filed 2016·Application pending·0 cites
- 1748US2008221138A1Method of using SAHA and Erlotinib for treating cancerBUNN PAUL·Filed 2008·Application pending·0 cites
- 1847US9434994B2Methods for prediction of clinical outcome to epidermal growth factor receptor inhibitors by non-small cell lung cancer patientsGARCIA MARILEILA VARELLA·Filed 2012·Granted Sep 6, 2016·0 cites·1 claims
- 1947US2008113874A1Gefitinib sensitivity-related gene expression and products and methods related theretoUNIV COLORADO·Filed 2007·Application pending·0 cites
- 2046US2012177641A1Gefitnib Sensitivity-Related Gene Expression and Products and Methods Related TheretoBUNN PAUL A·Filed 2012·Application pending·0 cites
- 2144US2012070442A1Methods and compositions for treating cancerWEISS GLEN JOEL·Filed 2008·Application pending·0 cites
- 2235US2008234265A1Histone Deacetylase Inhibitors Sensitize Cancer Cells to Epidermal Growth Factor InhibitorsUNIV COLORADO·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →